M. Grangeon

453 total citations
2 papers, 330 citations indexed

About

M. Grangeon is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Infectious Diseases. According to data from OpenAlex, M. Grangeon has authored 2 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pulmonary and Respiratory Medicine, 2 papers in Oncology and 0 papers in Infectious Diseases. Recurrent topics in M. Grangeon's work include Cancer Immunotherapy and Biomarkers (2 papers), Lung Cancer Research Studies (2 papers) and Lung Cancer Treatments and Mutations (2 papers). M. Grangeon is often cited by papers focused on Cancer Immunotherapy and Biomarkers (2 papers), Lung Cancer Research Studies (2 papers) and Lung Cancer Treatments and Mutations (2 papers). M. Grangeon collaborates with scholars based in France. M. Grangeon's co-authors include A. Jeanson, Fabrice Barlési, Céline Mascaux, M. Souquet-Bressand, Laurent Greillier, Pascale Tomasini, Mohamed Boucékine, S. Chaléat, Youssef Trigui and Julien Bermudez and has published in prestigious journals such as Journal of Thoracic Oncology and Clinical Lung Cancer.

In The Last Decade

M. Grangeon

2 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Grangeon France	2	297	188	54	51	33	2	330
S. Chaléat France	2	297 1.0×	188 1.0×	54 1.0×	51 1.0×	33 1.0×	2	330
M. Souquet-Bressand France	3	315 1.1×	206 1.1×	56 1.0×	66 1.3×	38 1.2×	3	361
T-E. Ciuleanu Romania	11	266 0.9×	240 1.3×	32 0.6×	57 1.1×	46 1.4×	47	345
Cor H. van der Leest Netherlands	7	206 0.7×	110 0.6×	93 1.7×	44 0.9×	26 0.8×	16	289
Weiheng Hu China	8	268 0.9×	154 0.8×	52 1.0×	59 1.2×	36 1.1×	35	334
Olivia Wilkins United States	5	309 1.0×	183 1.0×	51 0.9×	37 0.7×	16 0.5×	5	360
Guangming Tian China	10	291 1.0×	172 0.9×	54 1.0×	63 1.2×	43 1.3×	33	357
H.Z. Turna Türkiye	7	326 1.1×	264 1.4×	50 0.9×	48 0.9×	50 1.5×	8	367
Xiangjuan Ma China	9	274 0.9×	153 0.8×	53 1.0×	62 1.2×	33 1.0×	34	335
Elisabetta Gambale Italy	8	178 0.6×	116 0.6×	40 0.7×	47 0.9×	22 0.7×	19	246

Countries citing papers authored by M. Grangeon

Since Specialization

Citations

This map shows the geographic impact of M. Grangeon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Grangeon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Grangeon more than expected).

Fields of papers citing papers by M. Grangeon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Grangeon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Grangeon. The network helps show where M. Grangeon may publish in the future.

Co-authorship network of co-authors of M. Grangeon

This figure shows the co-authorship network connecting the top 25 collaborators of M. Grangeon. A scholar is included among the top collaborators of M. Grangeon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Grangeon. M. Grangeon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

2 of 2 papers shown

1.

Jeanson, A., Pascale Tomasini, M. Souquet-Bressand, et al.. (2019). Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology. 14(6). 1095–1101. 171 indexed citations

2.

Grangeon, M., Pascale Tomasini, S. Chaléat, et al.. (2018). Association Between Immune-related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Non–small-cell Lung Cancer. Clinical Lung Cancer. 20(3). 201–207. 159 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact